Allurion Technologies Inc (ALUR) Stock Price, Quote & News

Company Profile

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Tur...

Industry: Medical Devices

Sector: Healthcare

Phone: 508 647 4000

Website: www.allurion.com

Address:

11 Huron Drive, Natick, United States

Dizzier47 Sep. 12 at 12:35 PM

$ALUR bankruptcy or fda approval which comes first

1 · Reply

NVDAMillionaire Sep. 8 at 3:46 AM

$ALUR Really good write-up that perfectly summarizes ALUR's present situation. So if you want to bring your ALUR knowledge up to date or just discover ALUR, this is required reading. https://beyondspx.com/quote/ALUR/analysis/allurion-s-bold-reimagining-unlocking-value-in-the-obesity-market-with-glp-1-combination-therapy-nyse-alur

0 · Reply

Cattitude Sep. 4 at 8:30 PM

$ALUR GIVE US SOME NEWS PLEASE 🙏

1 · Reply

Blackberrys Sep. 3 at 12:07 PM

$ALUR looks good here to load 😜

0 · Reply

If_ur_not_first_ur_last Aug. 28 at 12:35 PM

$BEAT $ALUR final FD approval coming in hot $SPY

2 · Reply

DrKunta Aug. 28 at 1:01 AM

$ALUR they should announce the 45 days acceptance. There is the 15 and 45 days. They were late annoucing the 15 days. No wonder they are late announcing the 45-day decision

0 · Reply

luv1pocket Aug. 26 at 2:06 AM

$ALUR anybody have any idea when positive news will move this stock?

2 · Reply

Dani_G_German Aug. 25 at 11:45 AM

$ALUR

0 · Reply

ProDeal Aug. 25 at 2:34 AM

$ALUR https://www.zacks.com/stock/news/2737085/allurion-technologies-inc-alur-reports-q2-loss-misses-revenue-estimates?cid=CS-STOCKTWITS-HL-tale_of_the_tape|yseop_template_4-2737085&adid=SYND_STOCKTWITS_HEADLINE_TALEOFTHETAPE_513_2737085

0 · Reply

Dani_G_German Aug. 24 at 3:53 PM

$ALUR

0 · Reply

Allurion Technologies Inc. (ALUR) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 8:00 AM EDT - 4 weeks ago

Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 7, 2025, 4:05 PM EDT - 5 weeks ago

Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025

Aug 5, 2025, 8:00 AM EDT - 5 weeks ago

Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry

Jul 22, 2025, 8:00 AM EDT - 7 weeks ago

Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program

Jul 9, 2025, 4:05 PM EDT - 2 months ago

Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss

Jul 7, 2025, 8:00 AM EDT - 2 months ago

Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints

Jun 17, 2025, 8:00 AM EDT - 3 months ago

Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS

May 29, 2025, 4:05 PM EDT - 3 months ago

Allurion to Present at Jefferies Global Healthcare Conference

May 27, 2025, 4:05 PM EDT - 3 months ago

Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program

May 14, 2025, 2:44 PM EDT - 4 months ago

Allurion Technologies Inc. (ALUR) Q1 2025 Earnings Call Transcript

May 14, 2025, 8:00 AM EDT - 4 months ago

Allurion Reports First Quarter 2025 Financial Results and Provides Business Update

May 13, 2025, 4:05 PM EDT - 4 months ago

Allurion Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss

May 5, 2025, 4:05 PM EDT - 4 months ago

Allurion to Report First Quarter 2025 Financial Results on May 14, 2025

Apr 3, 2025, 4:30 PM EDT - 5 months ago

Allurion Announces Postponement of Special Meeting of Stockholders

Mar 26, 2025, 10:44 AM EDT - 6 months ago

Allurion Technologies Inc. (ALUR) Q4 2024 Earnings Call Transcript

Mar 26, 2025, 8:00 AM EDT - 6 months ago

Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Mar 20, 2025, 4:05 PM EDT - 6 months ago

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Mar 12, 2025, 4:05 PM EDT - 6 months ago

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025

Mar 4, 2025, 4:05 PM EST - 6 months ago

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

Feb 25, 2025, 4:05 PM EST - 7 months ago

Allurion to Participate in Upcoming Investor Conferences

Feb 20, 2025, 4:05 PM EST - 7 months ago

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Feb 19, 2025, 9:03 AM EST - 7 months ago

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Feb 18, 2025, 8:30 AM EST - 7 months ago

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Feb 13, 2025, 8:30 AM EST - 7 months ago

Allurion Relaunches in France

Jan 24, 2025, 1:25 PM EST - 8 months ago

Allurion Technologies Shares Are Up Today: What's Going On?

Jan 24, 2025, 11:50 AM EST - 8 months ago

Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs

Jan 24, 2025, 9:30 AM EST - 8 months ago

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market

Jan 23, 2025, 3:48 PM EST - 8 months ago

Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program

Jan 21, 2025, 8:30 AM EST - 8 months ago

Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity

Jan 14, 2025, 9:18 AM EST - 8 months ago

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

Jan 8, 2025, 8:00 AM EST - 8 months ago

Allurion Announces Positive Topline Results From AUDACITY Trial

Dec 24, 2024, 7:00 AM EST - 9 months ago

Allurion Technologies, Inc. Announces Reverse Stock Split

Dec 2, 2024, 8:00 AM EST - 10 months ago

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

Nov 25, 2024, 8:00 AM EST - 10 months ago

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

Nov 13, 2024, 12:43 PM EST - 10 months ago

Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 8:00 AM EST - 10 months ago

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 4, 2024, 8:10 AM EST - 11 months ago

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society's Annual Conference

Oct 30, 2024, 8:30 AM EDT - 11 months ago

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024

Oct 23, 2024, 8:00 AM EDT - 11 months ago

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon

Oct 9, 2024, 1:46 PM EDT - 1 year ago

October's 4 Best Penny Stocks: High-Risk, High-Reward Picks

GEVO KULR LUCD

Oct 9, 2024, 8:00 AM EDT - 1 year ago

Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss

Oct 1, 2024, 8:04 AM EDT - 1 year ago

Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss

Sep 5, 2024, 5:30 PM EDT - 1 year ago

Allurion Receives Continued Listing Standards Notice from NYSE

Sep 5, 2024, 8:00 AM EDT - 1 year ago

Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity

Sep 3, 2024, 8:00 AM EDT - 1 year ago

Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors

Aug 28, 2024, 8:28 AM EDT - 1 year ago

Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program

Aug 13, 2024, 10:18 AM EDT - 1 year ago

Allurion Technologies Inc. (ALUR) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update

Jul 16, 2024, 4:05 PM EDT - 1 year ago

Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024

Dizzier47 Sep. 12 at 12:35 PM

$ALUR bankruptcy or fda approval which comes first

1 · Reply

NVDAMillionaire Sep. 8 at 3:46 AM

0 · Reply

Cattitude Sep. 4 at 8:30 PM

$ALUR GIVE US SOME NEWS PLEASE 🙏

1 · Reply

Blackberrys Sep. 3 at 12:07 PM

$ALUR looks good here to load 😜

0 · Reply

If_ur_not_first_ur_last Aug. 28 at 12:35 PM

$BEAT $ALUR final FD approval coming in hot $SPY

2 · Reply

DrKunta Aug. 28 at 1:01 AM

$ALUR they should announce the 45 days acceptance. There is the 15 and 45 days. They were late annoucing the 15 days. No wonder they are late announcing the 45-day decision

0 · Reply

luv1pocket Aug. 26 at 2:06 AM

$ALUR anybody have any idea when positive news will move this stock?

2 · Reply

Dani_G_German Aug. 25 at 11:45 AM

$ALUR

0 · Reply

ProDeal Aug. 25 at 2:34 AM

0 · Reply

Dani_G_German Aug. 24 at 3:53 PM

$ALUR

0 · Reply

SignalCharger Aug. 23 at 5:24 AM

$ALUR Allurion Technologies is a medical device company with weight loss balloon facing adoption and reimbursement hurdles

0 · Reply

Maajk Aug. 22 at 7:06 PM

$ALUR Took a little nibble. Can we see an upswing? Or am I left with crumbles here

1 · Reply

Dani_G_German Aug. 22 at 4:18 PM

$ALUR looking good

1 · Reply

NonoACM Aug. 22 at 4:04 PM

$ALUR ñ

0 · Reply

Cattitude Aug. 20 at 3:16 PM

$ALUR I’m so bagged here lol

2 · Reply

jamesjanuary Aug. 20 at 1:48 PM

$ALUR medtronic is a shareholder and selling partner in some countries. and allurion's chairman is the former medtronic ceo. and medtronic just got an activist director who wants the company to do more deal and buy more assets. everything is lining up.

0 · Reply

d_risk Aug. 20 at 1:00 AM

$ALUR - ALLURION TECHNOLOGIES, INC. - 10Q - Updated Risk Factors ALUR flags risks from its restructuring and cost-cutting efforts potentially missing savings targets or disrupting operations, and warns that major shifts in U.S. federal policy could negatively impact the business. #RestructuringRisks #BusinessRisk #U.S.FederalPolicy #OperationalDisruption #CostCutting 🟢 Added 🟠 Removed https://d-risk.ai/ALUR/10-Q/2025-08-19

0 · Reply

Cattitude Aug. 19 at 8:05 PM

$ALUR

0 · Reply

luv1pocket Aug. 15 at 5:07 PM

$ALUR wonder if this drifts lower to $2 until it gets some partnership or a big announcement.

1 · Reply

Dani_G_German Aug. 14 at 2:25 PM

$NVO ozempic and wegovey will be obsolete soon $ALUR will be the go to treatment for weight loss and muscle retention non injection pill form. https://www.foxnews.com/health/popular-weight-loss-drugs-linked-sudden-vision-loss-research-suggests

1 · Reply

Dani_G_German Aug. 14 at 2:07 PM

$ALUR wow!!! She’s talking about Allurion! Load the boat! https://www.foxnews.com/health/popular-weight-loss-drugs-linked-sudden-vision-loss-research-suggests

0 · Reply

Dani_G_German Aug. 14 at 1:22 PM

$ALUR Ngl their cash position is my only worry

0 · Reply

Market Cap	17.00M
Revenue (ttm)	32.11M
Net Income (ttm)	-26.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-81.44%
Debt to Equity Ratio	0.00

Volume	33,900
Avg Vol	120,514
Day's Range	N/A - N/A
Shares Out	7.76M
Stochastic %K	48%
Beta	-0.46
Analysts	Strong Sell
Price Target	$8.38